Source: Global Research by Dr. Meryl Nass It is remarkable that a series of events taking place over the past 3 months produced a unified
The hydroxychloroquine (HCQ) arm of the trials had been stopped after publication of the Lancet Surgisphere study, which claimed that patients who received hydroxychloroquine had 35% higher death rates, but the Lancet study was retracted 13 days after publication, as its data turned out to be fabricated.
Source: The Guardian Questions continue for Surgisphere and CEO Sapan Desai as universities deny knowledge of links to firm behind Lancet’s now-disputed blockbuster study. Dozens
Source: ScienceDirect | PDF of full Journal Pre-Print Abstract In the context of the current COVID-19 pandemic, we conducted a meta-analysis on the effects of
Preface: On May 22, The Lancet published a study of 96,000 COVID-19 patients stating Hydroxychloroquine had no value in treating COVID-19 and even suggested increased
On the 25th of May 2020, the World Health Organisation halted hyrdoxychloroquine trials globally within 72 hours of sighting a publication in the Lancet. They
Source: The Guardian The World Health Organization and a number of national governments have changed their Covid-19 policies and treatments on the basis of flawed data from
Source: Indian Express In a statement, The Lancet said that “important scientific questions” were raised about data in the paper authored by cardiologist Mandeep Mehra,
Source: statnews The World Health Organization is resuming a clinical trial exploring whether the malaria drug hydroxychloroquine can effectively treat Covid-19, after pausing enrollment in
Source: The Lancet Expression of concern: Hydroxychloroquine or chloroquinewith or without a macrolide for treatment of COVID-19:a multinational registry analysis. Important scientific questions have been
Source: Science the Wire If you’re following at all the search for COVID-19 treatments, and possibly even if not, you will have seen the flurry
Source: France Soir Surgisphere is the company responsible for collecting data from Professor Mehra’s study, which has received worldwide attention for the past 7 days. After our first interview
Source: Medicine Uncensored by James M Todaro, MD (Columbia MD, @JamesTodaroMD)May 29, 2020, (updated May 30, 2020) Misinformation is bad. Misinformation in medicine is worse. Misinformation from a
SOURCE: Covexit.com The esteemed professor Paolo Zanotto, from the University of Sao Paulo, has released a list of 50 scientific references supporting the use of
Source: The White House His ExcellencyTHE WHITE HOUSEWASHINGTONMay 18, 2020 Dr. Tedros Adhanom GhebreyesusDirector-General of the World Health OrganizationGeneva, Switzerland Dear Dr. Tedros: On April
Source: PRNewswire The global hydroxychloroquine market size is expected to be worth around US$ 6 Bn by 2027 with CAGR of around 32%. The commercial market for hydroxychloroquin is
This study focuses on anti-malarial drugs like hydroxychloroquine, which have been seen as the most used treatment for COVID-19
Sermo’s Barometer studies have polled over 20,000 physicians globally regarding COVID-19 New York – April 17, 2020 – Hydroxychloroquine, a widely available and inexpensive drug initially
Responding to a question on the reaction of UN chief Antonio Guterres to India’s efforts to send Hydroxychloroquine and other supplies to other countries amidst
Percentage of New York Physicians Who Have Used Hydroxychloroquine Nearly Doubled, Italian and French Physicians Jumped 30% Points + Over 2 Weeks Week over week
Data from week two of largest ongoing international market research study on COVID-19 New York, New York – April 8, 2020 – Week two data of the
An international poll of thousands of doctors rated the Trump-touted anti-malaria drug hydroxychloroquine the best treatment for the novel coronavirus. Of the 2,171 physicians surveyed, 37 percent rated
FDA issued emergency authorization of Hydroxychloroquine treatment for COVID-19 patients in the USA. A global survey found that anti-malarial drug hydroxychloroquine was the most highly-rated
A drug combo already used against HIV. A malaria treatment first tested during World War II. A new antiviral whose promise against Ebola fizzled last
At the WHO’s media briefing on COVID-19, the Director-General’s opening remarks included: “WHO has been assessing this outbreak around the clock and we are deeply
Hydroxychloroquine (HCQ) appears as an additional therapy, as it possesses immunomodulatory and anti-thrombotic various effects [4-16].
Here, we summarize the results or design of clinical studies recently completed or initiated to evaluate the therapeutic activity of chloroquine derivatives in cancer patients.
